<DOC>
	<DOC>NCT02364466</DOC>
	<brief_summary>Prospective, observational cohort study of peripheral T cell lymphoma. Purpose is to investigate the complication including febrile neutropenia in the era of pegylated G-CSF prophylaxis.</brief_summary>
	<brief_title>Cohort of Peripheral T Cell Lymphoma</brief_title>
	<detailed_description>Prospective evaluation of frequencies of febrile neutropenia or infectious complications in a homogeneous population of patients with peripheral T cell lymphoma</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, T-Cell</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Lymphoma, T-Cell, Peripheral</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<criteria>1. Treatment naive peripheral T cell lymphoma Subtypes are as followings: Anaplastic large cell lymphoma angioimmunoblastic T cell lymphoma Peripheral T cell lymphomaNOS Enteropathyassociated T cell lymphoma Hepatosplenic Tcell lymphoma Subcutaneous panniculitislike Tcell lymphoma Primary cutaneous gammadelta Tcell lymphoma Primary cutaneous CD8+ aggressive epidermotropic lymphoma 2. Scheduled to receive chemotherapy of curative intent 3. 19 years old or over 4. Expected survival is more than 6 months 5. Informed consent 1. Other histology than those described above Extranodal NK/T cell lymphoma Other than peripheral T cell lymphoma 2. Other combined malignancy 3. Previous history of chemotherapy or radiation therapy 4. No informed consent</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>